Lineage Cell Therapeutics
LCTX
#8743
Rank
C$0.17 B
Marketcap
$0.77
Share price
-1.91%
Change (1 day)
-47.96%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of September 2024 : C$0.13 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are C$0.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$0.13 B-20.15%
2022-12-31C$0.16 B-24.56%
2021-12-31C$0.22 B61.61%
2020-12-31C$0.13 B-16.01%
2019-12-31C$0.16 B18.34%
2018-12-31C$0.13 B-36.42%
2017-12-31C$0.21 B13.68%
2016-12-31C$0.19 B45.91%
2015-12-31C$0.13 B51.07%
2014-12-31C$86.92 M41.44%
2013-12-31C$61.45 M107.74%
2012-12-31C$29.58 M-36.54%
2011-12-31C$46.61 M-12.46%
2010-12-31C$53.25 M276.75%
2009-12-31C$14.13 M1022.65%
2008-12-31C$1.25 M620.75%
2007-12-31C$0.17 M-76.94%
2006-12-31C$0.75 M-66.79%
2005-12-31C$2.28 M24.78%
2004-12-31C$1.82 M31.48%
2003-12-31C$1.39 M-41.17%
2002-12-31C$2.36 M-23.6%
2001-12-31C$3.09 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$0.43 B 212.72%๐Ÿ‡บ๐Ÿ‡ธ USA